This grant supports research to develop monoclonal antibodies against key emerging viruses, advancing candidates through preclinical and early clinical stages to boost EU pandemic preparedness.
Funds research to develop monoclonal antibody therapies for specific Flaviviruses, advancing clinical candidates and EU outbreak preparedness.
This grant funds research to discover and develop new small molecule antivirals for specific epidemic-prone viruses, supporting projects from early discovery through early-stage clinical studies.
Funds research to develop new antibacterial and antifungal therapies targeting specific drug-resistant pathogens to combat antimicrobial resistance and strengthen EU health leadership.
This grant supports expanding and coordinating European pandemic research networks, integrating clinical research, data, and stakeholders to strengthen pandemic preparedness and response.
This grant funds development and integration of human-based research methods and supports high-quality animal models to advance HIV/AIDS research while reducing animal use where possible.